The vaccine manufacturer Astrazeneca has admitted that “Vaxzevria” can have a serious side effect. This emerges from court documents in London, writes a newspaper.
A few days ago, a civil chamber of the Higher Regional Court (OLG) Bamberg sentenced the vaccine manufacturer Astrazeneca to provide comprehensive information about side effects of its corona vaccine “Vaxzevria”. Now the British daily newspaper “The Telegraph” reports that the company has already admitted a harmful side effect that was not previously listed – but before the London High Court, where Astrazeneca has to answer due to a class action lawsuit.
“In very rare cases it can cause TTS,” the newspaper quotes from the court document. TTS stands for thrombosis with thrombocytopenia syndrome. This leads to the formation of blood clots in rare places such as the brain or abdominal vessels and to a reduced blood platelet count.
TTS is a known possible complication after vaccination with Sars-CoV-2 vaccines. According to the Paul Ehrlich Institute, other vaccination reactions and side effects are primarily “temporary local reactions and general reactions” such as fatigue, fever, headaches, muscle pain or even chills. They are harmless and not associated with more serious or long-lasting illnesses.
Astrazeneca’s admission could lead to many individual plaintiffs being able to assert their claims for damages in addition to the class actions in Great Britain, the “Telegraph” and “Frankfurter Rundschau” estimate. There are currently 51 cases to be heard in London. This involves payments amounting to 100 million pounds.
The plaintiff suffered intestinal vein thrombosis
In Germany, a 33-year-old woman from Upper Franconia sued Astrazeneca. She was vaccinated with the Covid-19 vaccine from Astrazeneca in March 2021 and then suffered a so-called intestinal vein thrombosis. The woman fell into a coma and ultimately had to have part of her intestines removed.
She is demanding compensation and damages from the British-Swedish company. During the proceedings, the now successful lawsuit for information was added. Astrazeneca must provide the information for the period from December 27, 2020, when the vaccine was approved, to February 19, 2024.
Astrazeneca admits serious side effects from vaccine – 2024-05-06 20:41:40
Breast cancer, a new “hereditary form” discovered
It’s not just the “Jolie mutations”. Other genes, if mutated, can increase the hereditary risk of breast cancer. And among these, from today, there is also the CDH1 gene. The all-Italian discovery bears the signature of researchers from the European Institute of Oncology in Milan, authors of a study recently published in Jama Network Open. According to scholars, on all women with a particular type of breast cancer – the lobular one (which represents around 20% of cases) – and under the age of 45, or with a positive family history of breast cancer lobular or with bilateral lobular tumors should be tested for mutations in the CDH1 gene.
Tumors of unknown origin, artificial intelligence reconstructs the “path” of metastases backwards
by Sandro Iannaccone
From suspicion to confirmation
Researchers define it as a new form of cancer, or syndrome, called “hereditary lobular breast cancer” associated with the CDH1 gene. “Obviously discoveries like these don’t happen overnight – specifies a Salute Of Giovanni Corso, breast surgeon at the European Institute of Oncology and researcher at the University of Milan, first author of the paper – The first suspicions that this gene – already known for the predisposition of hereditary gastric cancer – could also be associated with lobular breast cancer date back to over 10 years ago. In 2016 I won a project from the Ministry of Health to set up a large study at the IEO that could test the hypothesis”.
Tumors, virtual reality can reduce pain
by Sara Carmignani
I study
5,400 women with lobular cancer were enrolled in the study. Of these, 394 with the “suspicious” phenotype (very young, with bilateral cancer or with a family history) were tested for the CDH1, BRCA1 and BRCA2 genes. And the results confirmed that intuition: approximately 5% had a variant of the CDH1 gene, without mutations in the BRCA1 and 2 genes. Although it is an uncommon syndrome, the probability that this variant is pathogenic (i.e. can cause the disease) is very high, around 40%. “We are talking about a mutation that is fortunately quite rare, but very aggressive, because it is associated with tumors that appear early, even more so than those associated with BRCA mutations,” underlines Corso.
Targeted screening and early diagnosis: this is how AI is changing medicine
by Sandro Iannaccone
Identify carriers of the mutation
It is therefore important to identify the carriers of this mutation, also because the lobular tumor is “more difficult” to see with normal mammography and ultrasound, and it is often necessary to resort to magnetic resonance imaging. “The opportunity for bilateral mastectomy in carriers of the mutation can be seriously considered on a case-by-case basis – says the researcher – Furthermore, it should not be forgotten that mutations in this gene are also linked to an increase in gastric cancer. We do not yet know why they are associated only with these two tumors, and the risk of also developing gastric cancer remains uncertain. But it is still possible, so annual gastroscopy is strongly recommended. The CDH1 test is therefore very important for both the woman and her family.”
Tumors, multidisciplinary treatment works more
by Sara Carmignani
To date, the national health system does not provide genetic testing for this female population, but the discovery opens up a new possibility: “We have already defined new clinical criteria for testing the CDH1 gene – concludes Corso – and they will also be published shortly in the new guidelines of the Italian Association of Medical Oncology”.
#Breast #cancer #hereditary #form #discovered
– 2024-05-06 17:14:58
Related posts:
Benefits of therapeutic massage for the body – Al-Marsad Libyan newspaper
Russia – Therapeutic massage is considered one of the most important methods that help get rid of muscle pain after accidents or health setbacks. This type of treatment has many benefits for the body’s health.
Regarding the topic, the Russian expert and specialist in therapeutic massage, Alexander Skripchenko, said: “There are various methods and techniques of massage approved in many countries of the world, including Chinese guasha massage, Thai massage, and Peruvian massage, and the benefits of these types of massage are not just a myth, but rather have positive effects.” On the health of the body in general. For example, Thai massage depends on the technique of sequential pressure on specific areas of the body, while Chinese Gua Sha massage uses tools that are passed along specific lines in the body. As a result of the difference in techniques, each type of massage has its benefits. Compared to classical medical massage methods, in general, various types of therapeutic massage have beneficial effects.”
Skripchenko pointed out that therapeutic massage performed by a qualified specialist can improve the condition of the musculoskeletal system and the condition of the nervous system in the body. Indeed, this method of treatment helps improve the condition of the internal organs, helps increase immunity, and improves the body’s overall health.
The expert stressed the necessity of resorting to specialized centers that include qualified specialists if a person wishes to receive a therapeutic massage, as improper massage can cause problems in the muscles, nervous system, and even problems in the joints and bones.
Source: Vesti
#Benefits #therapeutic #massage #body #AlMarsad #Libyan #newspaper
2024-05-06 17:50:01
Related posts:
Benefits of therapeutic massage for the body – Al-Marsad Libyan newspaper